Ann: Cellmid raises $4M to leverage sales growth, page-147

Four of many in the wind...

1. The Company’s collaborations have been expanded with the signing of two material transfer agreements with undisclosed parties, and received a royalty payment from its licensee.

4. Selling the Company’s FGF5 inhibitor products through private label supply agreements is
a key expansion strategy for Cellmid. The Company is currently in negotiations with a
number of international brand owners to grow this business further in the future. Utilising
established brand names and distirbution channels compliments Cellmid’s drive to build
its own évolis® brand.

3. Advertise nationally. A campaign is planned from September 2015 to develop and make highly visible a unique évolis® brand and to drive consumers to purchase. Media will include a strong digital component.


4. Initial sales of Andeprong® Scientist indicate that Natural Garden will be able to achieve its target of 30,000 unit sales per year. QVC continues to be an important sales channel during the coming months. Other sales channels, such as private label (own brand) products.


+ Quest
+ Zoeist
+ GWP
+ Fujikura
+ Pacific Edge
+ ?? $$